Concepedia

Maoxia Zheng

MZ

Statistics

Publications

5

Citations

3.8K

H-Index

5

Active since

2009

Affiliations

Neurological Surgery(Current)

Maoxia Zheng is an author at Neurological Surgery specializing in cancer immunotherapy, pharmacology, and oncology.

Publications per year

2009–2023

5

Publications

5

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2009 · 2.4K citations

, , +17

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy

Howard A. Burris, Hope S. Rugo, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2010 · 764 citations · Full text

, , +17

A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine

Ian E. Krop, Patricia LoRusso, Kathy D. Miller et al. · Journal of Clinical Oncology · 2012 · 362 citations · Full text

, , +17

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2023 · 183 citations

, , +17

Quantitative assessment of diagnostic markers and correlations with efficacy in two phase II studies of trastuzumab-DM1 (T-DM1) for patients (pts) with metastatic breast cancer (MBC) who had progressed on prior HER2-directed therapy.

P. LoRusso, Ian E. Krop, H.A. Burris et al. · Journal of Clinical Oncology · 2010 · 16 citations

, , +17

1–5 of 5